Occudo Quantitative Strategies’s inTEST INTT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
58,463
+28,619
+96% +$484K 0.06% 373
2026
Q1
$558K Buy
+29,844
New +$327K 0.03% 481
2024
Q2
Sell
-12,965
Closed -$172K 868
2024
Q1
$172K Buy
+12,965
New +$153K 0.03% 612
2023
Q4
Sell
-17,303
Closed -$262K 973
2023
Q3
$262K Sell
17,303
-15,643
-47% -$289K 0.03% 717
2023
Q2
$865K Buy
32,946
+14,580
+79% +$321K 0.09% 377
2023
Q1
$381K Buy
+18,366
New +$276K 0.03% 590
2022
Q2
Sell
-10,485
Closed -$113K 1249
2022
Q1
$113K Hold
10,485
0.01% 1009
2021
Q4
$133K Sell
10,485
-934
-8% -$12.1K 0.01% 930
2021
Q3
$131K Buy
11,419
+443
+4% +$5.9K 0.02% 901
2021
Q2
$184K Buy
+10,976
New +$148K 0.03% 732

Other funds holding INTT

Occudo Quantitative Strategies's INTT Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its inTEST (INTT) stake by 96% in Q2 2026, buying an estimated $484K and bringing the position to 58,463 shares worth $1.06M. The position accounts for 0.06% of the portfolio, ranked #373.

Occudo Quantitative Strategies first reported a position in INTT in Q2 2021 and has held it in 10 quarters since. 90 funds tracked by Wall St. Rank hold INTT as of Q2 2026.

  • Occudo Quantitative Strategies held 58,463 shares of inTEST worth $1.06M as of Q2 2026.
  • Occudo Quantitative Strategies bought 28,619 inTEST shares in Q2 2026, an estimated $484K.
  • inTEST made up 0.06% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #373 holding.
  • Occudo Quantitative Strategies first reported a position in inTEST in Q2 2021 and has held it in 10 quarters since.
  • 90 funds tracked by Wall St. Rank held inTEST as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.